Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ahmed Ullah Mishuk, Li Chen, Chao Li, Nan Huo, Richard A. Hansen, Ilene Harris, Zippora Kiptanui & Jingjing Qian. (2021) Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study. Current Medical Research and Opinion 37:4, pages 655-664.
Read now
Read now
Sidra Mahmood, Shahzad Hussain, Taufeeq ur Rehman, Corrado Barbui, Amanj Baker Kurdi & Brian Godman. (2019) Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Current Medical Research and Opinion 35:1, pages 51-61.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Brian Godman, Anna Bucsics, Thomas Burkhardt, Manuela Schmitzer, Björn Wettermark & Peter Wieninger. (2010) Initiatives to enhance renin–angiotensin prescribing efficiency in Austria: impact and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 10:2, pages 199-207.
Read now
Read now
Diane McGinn, Brian Godman, Julie Lonsdale, Rosalind Way, Björn Wettermark & Alan Haycox. (2010) Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications. Expert Review of Pharmacoeconomics & Outcomes Research 10:1, pages 73-85.
Read now
Read now
Articles from other publishers (16)
RajeshB Hadia, DhavalB Joshi, KushalH Gohel & Nikhil Khambhati. (2022) Knowledge, attitude, and practice of generic medicines among physicians at multispecialty hospital: An observational study. Perspectives in Clinical Research 13:3, pages 155.
Crossref
Crossref
Josephine Walker, Betty B. Chaar, Numa Vera, Alvish S. Pillai, Jessy S. Lim, Lisa Bero & Rebekah J. Moles. (2017) Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views. PLOS ONE 12:6, pages e0178429.
Crossref
Crossref
Grzegorz Cessak, Konrad Rokita, Marta Dąbrowska, Katarzyna Sejbuk– Rozbicka, Anna Zaremba, Dagmara Mirowska-Guzel & Ewa Bałkowiec-Iskra. (2016) Therapeutic equivalence of antipsychotics and antidepressants – A systematic review. Pharmacological Reports 68:2, pages 217-223.
Crossref
Crossref
Slawomir Murawiec, Aleksandra Rajewska-Rager, Jerzy Samochowiec, Sylwia Kalinowska, Jacek Kurpisz, Joanna Krzyzanowska, Halina Sienkiewicz-Jarosz, Iwona Kurkowska-Jastrzebska, Agnieszka Samochowiec & Przemyslaw Bienkowski. (2015) Pharmacy switch of antipsychotic medications: patient’s perspective. Annals of General Psychiatry 14:1.
Crossref
Crossref
H. Gothe, I. Schall, K. Saverno, M. Mitrovic, A. Luzak, D. Brixner & U. Siebert. (2015) The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review. Applied Health Economics and Health Policy 13:S1, pages 21-33.
Crossref
Crossref
Ewa Bałkowiec-Iskra, Grzegorz Cessak, Olga Kuzawińska, Katarzyna Sejbuk-Rozbicka, Konrad Rokita & Dagmara Mirowska-Guzel. (2015) Regulatory and clinical aspects of psychotropic medicinal products bioequivalence. European Neuropsychopharmacology 25:7, pages 1027-1034.
Crossref
Crossref
Brian Godman, Max Petzold, Kathleen Bennett, Marion Bennie, Anna Bucsics, Alexander E Finlayson, Andrew Martin, Marie Persson, Jutta Piessnegger, Emanuel Raschi, Steven Simoens, Corinne Zara & Corrado Barbui. (2014) Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications. BMC Medicine 12:1.
Crossref
Crossref
Marina Polić-Vižintin, Danijela Štimac, Zvonimir Šostar & Ingrid Tripković. (2014) Distribution and trends in outpatient utilization of generic versusbrand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Services Research 14:1.
Crossref
Crossref
Suzanne Dunne, Bill Shannon, Colum Dunne & Walter Cullen. (2013) A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Rani Samuel, Azizah Attard & Marinos Kyriakopoulos. (2013) Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study. BMC Psychiatry 13:1.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Crossref
Maren Carbon & Christoph U. Correll. (2013) Rational Use of Generic Psychotropic Drugs. CNS Drugs 27:5, pages 353-365.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Julie Eve Desmarais, Linda Beauclair & Howard C. Margolese. (2011) Switching from Brand-Name to Generic Psychotropic Medications: A Literature Review. CNS Neuroscience & Therapeutics 17:6, pages 750-760.
Crossref
Crossref
Magda Wladysiuk, Aleksander Araszkiewicz, Brian Godman, Katarzyna Szabert, Corrado Barbui & Alan Haycox. (2011) Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland. Applied Health Economics and Health Policy 9:2, pages 101-110.
Crossref
Crossref
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, F. Cankat Tulunay, Kamila Wendykowska, Corinne Zara & Lars L Gustafsson. (2010) Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?. Pharmaceuticals 3:8, pages 2470-2494.
Crossref
Crossref